1 Clinical failure |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
1.1 6 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
1.2 12 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
4.39 [0.22, 87.82] |
2 Radiological failure |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
2.1 6 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.55 [0.22, 1.39] |
2.2 12 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.42 [0.17, 1.02] |
3 Pain |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
3.1 6 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
3.2 12 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
4 Soft tissue pathology |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
4.1 6 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
4.2 12 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.29 [0.01, 6.91] |
5 Adjacent tissue inflammation |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
5.1 6 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
5.2 12 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.31 [0.03, 2.91] |
6 Pathologic mobility |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
6.1 6 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
6.2 12 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
7 Pathologic radiolucency |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
7.1 6 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.88 [0.06, 13.35] |
7.2 12 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.56 [0.07, 4.17] |
8 Pathologic root resorption |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
8.1 6 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.51 [0.18, 1.42] |
8.2 12 months |
2 |
110 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.38 [0.15, 1.01] |